X
X4 Pharmaceuticals
Clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment
About X4 Pharmaceuticals
X4 Pharmaceuticals was founded in 2014 by a team of biotech veterans: Raj Parekh, Irving Fain, Alan Walts, Paula Ragan, and Brent Emmett. The company is headquartered in Boston, Massachusetts, and focuses on developing novel therapies for rare diseases.
Read full description
From its inception, X4 Pharmaceuticals aimed to address the unmet needs of patients with rare diseases by improving immune cell trafficking. This focus on rare diseases allowed the company to carve out a niche in the biopharmaceutical industry.
In its journey, X4 Pharmaceuticals achieved a significant milestone by going public. This move not only provided the company with the capital needed to advance its research and development efforts but also increased its visibility in the competitive biotech market.
Throughout its history, X4 Pharmaceuticals has remained committed to its mission of developing innovative treatments that can significantly improve the lives of patients with rare diseases. The company's dedication to research and development continues to drive its progress and impact in the field of biopharmaceuticals.
At a glance
- Status
- Listed
- Founded
- 2014
- Headquarters
- Cambridge, United States
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later1 investor entered at this stage
Hercules Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about X4 Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See X4 Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.